Economic Environment: Broad economic growth or recession affects overall market sentiment, influencing stock prices. Strong economic data often boosts investor confidence.

Company Performance: Revenue growth, profitability, and market share directly impact investor perception and stock valuation. Strong financial results generally lead to price increases.

Industry Trends: The performance of the broader pharmaceutical industry, including innovation, regulatory changes, and competitive landscape, influences the outlook for individual companies.

Regulatory Changes: Government policies related to healthcare, drug pricing, and approvals significantly affect the company's operations and profitability, impacting stock price.

Market Sentiment: Overall investor mood, fear, and greed can drive short-term price fluctuations, regardless of fundamental factors. News and rumors play a significant role.

Company News: Significant events like new drug approvals, clinical trial results, mergers, or acquisitions can trigger immediate price reactions, positive or negative.

Interest Rates: Changes in interest rates affect the cost of capital and investment attractiveness, influencing stock valuations and investor decisions.

Global Events: Major global events like pandemics, trade wars, or geopolitical instability can create market volatility and impact investor risk appetite.

Supply Chain Issues: Disruptions in the supply chain for raw materials or finished products can impact production costs and revenue, potentially affecting the stock price.

Investor Confidence: How investors perceive the company's management team, future prospects, and overall strategy directly impacts their willingness to buy or sell shares.